International Journal of Pharmaceutics: X最新文献

筛选
英文 中文
Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions 基于二元固体脂质基质的布洛芬负载固体脂质纳米颗粒增强稳定性和皮肤渗透性:表面活性剂和脂质成分的影响
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-08-10 DOI: 10.1016/j.ijpx.2023.100205
Thitirat Chantaburanan, Veerawat Teeranachaideekul, Anchalee Jintapattanakit, Doungdaw Chantasart, Varaporn Buraphacheep Junyaprasert
{"title":"Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions","authors":"Thitirat Chantaburanan,&nbsp;Veerawat Teeranachaideekul,&nbsp;Anchalee Jintapattanakit,&nbsp;Doungdaw Chantasart,&nbsp;Varaporn Buraphacheep Junyaprasert","doi":"10.1016/j.ijpx.2023.100205","DOIUrl":"10.1016/j.ijpx.2023.100205","url":null,"abstract":"<div><h3>Hypothesis</h3><p>The type of emulsifier selected has an impact on the physicochemical properties of solid lipid nanoparticles (SLNs). This study was designed to compare the effects of emulsifiers on the physicochemical properties and <em>in vitro</em> skin performance of SLNs prepared from a binary mixture of Softisan® 378 (S378) and cetyl palmitate (CP) to those of SLNs prepared from only CP and S378.</p></div><div><h3>Experiments</h3><p>SLNs were prepared from CP, S378, or a binary mixture of CP and S378 (1:1 <em>w</em>/w) as the lipid phase and stabilized with Tego®Care 450 (TG450) or poloxamer 188 (P188) containing 1.0% <em>w</em>/w ibuprofen loading. The physicochemical properties including the particle size, polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (E.E.), crystallinity (%CI), and polymorphism were determined after production and after storage for 180 days under different conditions. In addition, <em>in vitro</em> drug release and permeation through human skin was studied after production and storage at room temperature for 180 days.</p></div><div><h3>Finding</h3><p>The particle sizes of ibuprofen-loaded SLNs (IBSLNs) stabilized with P188 (IBSLN-P188) were smaller than those of SLNs stabilized with TG450 (IBSLN-TG450) (<em>p</em> &lt; 0.05). After 180 days, the particle sizes of the IBSLNs were slightly increased compared to those at the initial time but were &lt;250 nm. The IBSLN-TG450 sample showed a higher %CI than IBSLN-P188 prepared with similar propotions of CP and S378, and ibuprofen crystals were observed in the IBSLN1-TG450 sample after storage at 4 °C for 180 days. Based on the result of the <em>in vitro</em> release study and the <em>in vitro</em> skin permeation test, the addition of S378 into the CP-matrix modified ibuprofen release and skin permeation both permeated ibuprofen through the epidermis and retained ibuprofen in the epidermis. In addition, the storage time affected the release and skin permeation of ibuprofen from the SLNs, which depended on the composition of the IBSLNs.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100205"},"PeriodicalIF":4.7,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/1d/main.PMC10440359.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process 一种通过碾压和干燥造粒工艺来支持片剂配方设计的片性变化分级系统
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-28 DOI: 10.1016/j.ijpx.2023.100204
Junhui Su , Kunfeng Zhang , Feiyu Qi , Junjie Cao , Yuhua Miao , Zhiqiang Zhang , Yanjiang Qiao , Bing Xu
{"title":"A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process","authors":"Junhui Su ,&nbsp;Kunfeng Zhang ,&nbsp;Feiyu Qi ,&nbsp;Junjie Cao ,&nbsp;Yuhua Miao ,&nbsp;Zhiqiang Zhang ,&nbsp;Yanjiang Qiao ,&nbsp;Bing Xu","doi":"10.1016/j.ijpx.2023.100204","DOIUrl":"10.1016/j.ijpx.2023.100204","url":null,"abstract":"<div><p>In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125–250 μm) and large granules (630–850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (<em>CoT</em><sub>r</sub>) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100204"},"PeriodicalIF":4.7,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10027453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidation of polysorbates – An underestimated degradation pathway? 聚山梨酯的氧化-一个被低估的降解途径?
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-27 DOI: 10.1016/j.ijpx.2023.100202
Johanna Weber , Julia Buske , Karsten Mäder , Patrick Garidel , Tim Diederichs
{"title":"Oxidation of polysorbates – An underestimated degradation pathway?","authors":"Johanna Weber ,&nbsp;Julia Buske ,&nbsp;Karsten Mäder ,&nbsp;Patrick Garidel ,&nbsp;Tim Diederichs","doi":"10.1016/j.ijpx.2023.100202","DOIUrl":"10.1016/j.ijpx.2023.100202","url":null,"abstract":"<div><p>To ensure the stability of biologicals over their entire shelf-life, non-ionic surface-active compounds (surfactants) are added to protect biologics from denaturation and particle formation. In this context, polysorbate 20 and 80 are the most used detergents. Despite their benefits of low toxicity and high biocompatibility, specific factors are influencing the intrinsic stability of polysorbates, leading to degradation, loss in efficacy, or even particle formation. Polysorbate degradation can be categorized into chemical or enzymatic hydrolysis and oxidation. Under pharmaceutical relevant conditions, hydrolysis is commonly originated from host cell proteins, whereas oxidative degradation may be caused by multiple factors such as light, presence of residual metal traces, peroxides, or temperature, which can be introduced upon manufacturing or could be already present in the raw materials. In this review, we provide an overview of the current knowledge on polysorbates with a focus on oxidative degradation. Subsequently, degradation products and key characteristics of oxidative-mediated polysorbate degradation in respect of different types and grades are summarized, followed by an extensive comparison between polysorbate 20 and 80. A better understanding of the radical-induced oxidative PS degradation pathway could support specific mitigation strategies. Finally, buffer conditions, various stressors, as well as appropriate mitigation strategies, reagents, and alternative stabilizers are discussed. Prior manufacturing, careful consideration and a meticulous risk-benefit analysis are highly recommended in terms of polysorbate qualities, buffers, storage conditions, as well as mitigation strategies.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100202"},"PeriodicalIF":4.7,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/31/main.PMC10480556.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10539103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Impact of polymer chemistry on critical quality attributes of selective laser sintering 3D printed solid oral dosage forms 聚合物化学对选择性激光烧结3D打印固体口服剂型关键质量属性的影响
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-26 DOI: 10.1016/j.ijpx.2023.100203
Tikhomirov Evgenii , Levine Valerie , Åhlén Michelle , Di Gallo Nicole , Strømme Maria , Kipping Thomas , Quodbach Julian , Lindh Jonas
{"title":"Impact of polymer chemistry on critical quality attributes of selective laser sintering 3D printed solid oral dosage forms","authors":"Tikhomirov Evgenii ,&nbsp;Levine Valerie ,&nbsp;Åhlén Michelle ,&nbsp;Di Gallo Nicole ,&nbsp;Strømme Maria ,&nbsp;Kipping Thomas ,&nbsp;Quodbach Julian ,&nbsp;Lindh Jonas","doi":"10.1016/j.ijpx.2023.100203","DOIUrl":"10.1016/j.ijpx.2023.100203","url":null,"abstract":"<div><p>The aim of this study is to investigate the influence of polymer chemistry on the properties of oral dosage forms produced using selective laser sintering (SLS). The dosage forms were printed using different grades of polyvinyl alcohol or copovidone in combination with indomethacin as the active pharmaceutical ingredient. The properties of the printed structures were assessed according to European Pharmacopoeia guidelines at different printing temperatures and laser scanning speeds in order to determine the suitable printing parameters.</p><p>The results of the study indicate that the chemical properties of the polymers, such as dynamic viscosity, degree of hydrolyzation, and molecular weight, have significant impact on drug release and kinetics. Drug release rate and supersaturation can be modulated by selecting the appropriate polymer type. Furthermore, the physical properties of the dosage forms printed under the same settings are influenced by the selected polymer type, which determines the ideal manufacturing settings.</p><p>This study demonstrates how the chemical properties of the polymer can determine the appropriate choice of manufacturing settings and the final properties of oral dosage forms produced using SLS.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100203"},"PeriodicalIF":4.7,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bd/b4/main.PMC10410523.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9976152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study 作为左氧氟沙星眼部给药的一种有前景的方法:体外表征、微生物学评估、角膜渗透性和体内研究
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-24 DOI: 10.1016/j.ijpx.2023.100201
Omnia Ahmed Agha , Germeen N.S. Girgis , Mohamed M.A. El-Sokkary , Osama Abd El-Azeem Soliman
{"title":"Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study","authors":"Omnia Ahmed Agha ,&nbsp;Germeen N.S. Girgis ,&nbsp;Mohamed M.A. El-Sokkary ,&nbsp;Osama Abd El-Azeem Soliman","doi":"10.1016/j.ijpx.2023.100201","DOIUrl":"10.1016/j.ijpx.2023.100201","url":null,"abstract":"<div><p>The objective of this study was to encapsulate the antibacterial drug levofloxacin hemihydrate (LF) into spanlastics (SLs) followed by incorporation into gelrite in situ gel to enhance its antibacterial activity and sustain ocular delivery. A combination of Span 60 as main vesicle component and Tweens as an edge activator (EA) was used to prepare SLs using the thin film hydration method. A 3<sup>2</sup> factorial design was applied to study the effect of formulation variables (ratio of Span 60: EA and type of EA) on SLs characteristics (encapsulation efficiency (EE%), particle size (PS), zeta potential (ZP) and percentage of drug released). In-vitro antimicrobial study was conducted to determine the antibacterial activity of the optimized formula. Finally confocal laser scanning microscopy (CLSM) was applied to monitor SLs corneal penetration. The optimum formulation (F5), contains 240 mg Span 60 and 60 mg Tween 60 as EA. F5 exhibited EE% = 59.7 ± 4.2%, PS = 177.6 ± 1.8 nm, PDI = 0.27 ± 0.022 and ZP = -40.6 ± 0.68 mV. Furthermore, only 39.37 ± 0.72% of LF amount was released after 4 h compared to complete release from drug solution. The apparent permeation coefficient was (14.7 × 10<sup>−3</sup> cm/h) compared to (9.7 × 10<sup>−3</sup> cm/h) for LF solution. Moreover, F5 exhibited 200% and 100% increase in the antibacterial efficacy against <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> respectively.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100201"},"PeriodicalIF":4.7,"publicationDate":"2023-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/ad/main.PMC10407905.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9974092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymorphic transitions in flufenamic acid-trehalose composites 氟胺酸-海藻糖复合物的多态转变
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-23 DOI: 10.1016/j.ijpx.2023.100200
Yuying Pang , Simon Gaisford , Oxana V. Magdysyuk , Gareth R. Williams
{"title":"Polymorphic transitions in flufenamic acid-trehalose composites","authors":"Yuying Pang ,&nbsp;Simon Gaisford ,&nbsp;Oxana V. Magdysyuk ,&nbsp;Gareth R. Williams","doi":"10.1016/j.ijpx.2023.100200","DOIUrl":"10.1016/j.ijpx.2023.100200","url":null,"abstract":"<div><p>The combination of poorly-soluble drugs with small molecule co-formers to generate amorphous solid dispersions (ASDs) has great potential to improve dissolution rate and kinetic solubility, and thus increase the bioavailability of these active ingredients. However, such ASDs are known to be unstable and to crystallise upon storage or heating. In this work, we explore the crystallisation of flufenamic acid (FFA) from ASDs prepared with trehalose. FFA-trehalose mixtures were prepared at a range of <em>w</em>/w composition ratios, heated to melting and crash cooled to form ASDs. They were then subject to a further heat/cool cycle, which was monitored by simultaneous differential scanning calorimetry – X-ray diffraction to observe the phase changes occurring. These varied with the composition of the blend. Upon short-term storage, formulations with low trehalose contents (FFA:trehalose 5:1 <em>w</em>/w) recrystallised into form I FFA, while higher trehalose contents crystallised to FFA form IV. When heated, all FFA trehalose combinations ultimately recrystallised into form I before melting. Upon a second cooling cycle, systems with low trehalose content (FFA:trehalose 5:1 <em>w</em>/w) recrystallised into form IV, while higher trehalose contents led to FFA form I. It is thus clear that even with a single excipient it is possible to control the crystallisation pathway through judicious choice of the formulation parameters.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100200"},"PeriodicalIF":4.7,"publicationDate":"2023-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9978140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation of chitosan-coated hollow tin dioxide nanoparticles and their application in improving the oral bioavailability of febuxostat 壳聚糖包被中空二氧化锡纳米颗粒的制备及其在提高非布司他口服生物利用度中的应用
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-13 DOI: 10.1016/j.ijpx.2023.100199
Junpeng Sun , Jiaqun Du , Xiaobang Liu , Jinyu An , Yingqiao Li , Yanan Yu , Minghui Li , Li Zheng , Chao Wu , Lili Hu
{"title":"Preparation of chitosan-coated hollow tin dioxide nanoparticles and their application in improving the oral bioavailability of febuxostat","authors":"Junpeng Sun ,&nbsp;Jiaqun Du ,&nbsp;Xiaobang Liu ,&nbsp;Jinyu An ,&nbsp;Yingqiao Li ,&nbsp;Yanan Yu ,&nbsp;Minghui Li ,&nbsp;Li Zheng ,&nbsp;Chao Wu ,&nbsp;Lili Hu","doi":"10.1016/j.ijpx.2023.100199","DOIUrl":"10.1016/j.ijpx.2023.100199","url":null,"abstract":"<div><p>The aim of this study was to design a chitosan-coated hollow tin dioxide nanosphere (CS-HSn) for loading febuxostat (FEB) using an adsorption method to obtain a sustained-release system (CS-HSn-FEB) to improve the oral bioavailability of FEB. The morphological characteristics of hollow tin dioxide nanospheres (HSn) and CS-HSn were analyzed by transmission electron microscopy (TEM) and dynamic light scattering (DLS). The hemolysis test and CCK-8 test were used to assess the biosafety of HSn and CS-HSn. Powder X-ray diffraction (PXRD) and differential scanning thermal analysis (DSC) were performed on CS-HSn-FEB to analyze the drug presence status. The dissolution behavior and changes in plasma drug concentration of CS-HSn-FEB were evaluated in vitro and in vivo. Sections of intestinal tissues from SD rats were obtained to observe whether chitosan could increase the distribution of nanoparticles in the intestinal tissues. The results showed that FEB was present in CS-HSn in an amorphous state. Moreover, CS-HSn, with good biosafety, significantly improved the water solubility and oral absorption of FEB, indicating that CS-HSn has great potential to improve the intestinal absorption and oral bioavailability of insoluble drugs.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100199"},"PeriodicalIF":4.7,"publicationDate":"2023-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/42/c2/main.PMC10384222.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9910263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles 用于复合siRNA的阳离子脂质用量对siRNA-固体脂质纳米颗粒细胞毒性和促炎活性的影响
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-03 DOI: 10.1016/j.ijpx.2023.100197
Mahmoud S. Hanafy , Huy M. Dao , Haiyue Xu , John J. Koleng , Wedad Sakran , Zhengrong Cui
{"title":"Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles","authors":"Mahmoud S. Hanafy ,&nbsp;Huy M. Dao ,&nbsp;Haiyue Xu ,&nbsp;John J. Koleng ,&nbsp;Wedad Sakran ,&nbsp;Zhengrong Cui","doi":"10.1016/j.ijpx.2023.100197","DOIUrl":"10.1016/j.ijpx.2023.100197","url":null,"abstract":"<div><p>When preparing siRNA-encapsulated solid lipid nanoparticles (siRNA-SLNs), cationic lipids are commonly included to condense and lipophilize the siRNA and thus increase its encapsulation in the SLNs. Unfortunately, cationic lipids also contribute significantly to the cytotoxicity and proinflammatory activity of the SLNs. Previously, our group developed a TNF-α siRNA-SLN formulation that showed strong activity against rheumatoid arthritis unresponsive to methotrexate in a mouse model. The siRNA-SLNs were composed of lecithin, cholesterol, an acid-sensitive stearoyl polyethylene glycol (2000) conjugate, and siRNA complexes with 1,2-dioleoyl-3trimethylammonium-propane (DOTAP), a cationic lipid. The present study was designed to study the effect of the amount of DOTAP used to complex the siRNA on the cytotoxicity and proinflammatory activity of the resultant siRNA-SLNs. A small library of siRNA-SLNs prepared at various ratios of DOTAP to siRNA (i.e., nitrogen to phosphate (N/P) ratios ranging from 34:1 to 1:1) were prepared and characterized, and the cytotoxicity and proinflammatory activity of selected formulations were evaluated in cell culture. As expected, the siRNA-SLNs prepared at the highest N/P ratio showed the highest cytotoxicity to J774A.1 macrophage cells and reducing the N/P ratio lowered the cytotoxicity of the siRNA-SLNs. Unexpectedly, the cytotoxicity of the siRNA-SLNs reached the lowest at the N/P ratios of 16:1 and 12:1, and further reducing the N/P ratio resulted in siRNA-SLNs with increased cytotoxicity. For example, siRNA-SLNs prepared at the N/P ratio of 1:1 was more cytotoxic than the ones prepared at the N/P ratio 12:1. This finding was confirmed using neutrophils differentiated from mouse MPRO cell line. The DOTAP release from the siRNA-SLNs prepared at the N/P ratio of 1:1 was faster than from the ones prepared at the N/P ratio of 12:1. The siRNA-SLNs prepared at N/P ratios of 12:1 and 1:1 showed comparable proinflammatory activities in both macrophages and neutrophils. Additionally, the TNF-α siRNA-SLNs prepared at the N/P ratios of 12:1 and 1:1 were equally effective in downregulating TNF-α expression in J774A.1 macrophages. In conclusion, it was demonstrated that at least in vitro in cell culture, reducing the amount of cationic lipids used when preparing siRNA-SLNs can generally help reduce the cytotoxicity of the resultant SLNs, but siRNA-SLNs prepared with the lowest N/P ratio are not necessarily the least cytotoxic and proinflammatory.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100197"},"PeriodicalIF":4.7,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ab/bd/main.PMC10371828.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10294654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly protein-loaded melt extrudates produced by small-scale ram and twin-screw extrusion - evaluation of extrusion process design on protein stability by experimental and numerical approaches 小规模冲压和双螺杆挤出生产的高蛋白熔体挤出物——用实验和数值方法评估挤出工艺设计对蛋白质稳定性的影响
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-07-01 DOI: 10.1016/j.ijpx.2023.100196
Katharina Dauer , Kevin Kayser , Felix Ellwanger , Achim Overbeck , Arno Kwade , Heike P. Karbstein , Karl G. Wagner
{"title":"Highly protein-loaded melt extrudates produced by small-scale ram and twin-screw extrusion - evaluation of extrusion process design on protein stability by experimental and numerical approaches","authors":"Katharina Dauer ,&nbsp;Kevin Kayser ,&nbsp;Felix Ellwanger ,&nbsp;Achim Overbeck ,&nbsp;Arno Kwade ,&nbsp;Heike P. Karbstein ,&nbsp;Karl G. Wagner","doi":"10.1016/j.ijpx.2023.100196","DOIUrl":"10.1016/j.ijpx.2023.100196","url":null,"abstract":"<div><p>Understanding of generation, extent and location of thermomechanical stress in small-scale (&lt; 3 g) ram and twin-screw melt-extrusion is crucial for mechanistic correlations to the stability of protein particles (lysozyme and BSA) in PEG-matrices. The aim of the study was to apply and correlate experimental and numerical approaches (1D and 3D) for the evaluation of extrusion process design on protein stability. The simulation of thermomechanical stress during extrusion raised the expectation of protein degradation and protein particle grinding during extrusion, especially when TSE was used. This was confirmed by experimental data on protein stability. Ram extrusion had the lowest impact on protein unfolding temperatures, whereas TSE showed significantly reduced unfolding temperatures, especially in combination with kneading elements containing screws. In TSE, the mechanical stress in the screws always exceeded the shear stress in the die, while mechanical stress within ram extrusion was generated in the die, only. As both extruder designs revealed homogeneously distributed protein particles over the cross section of the extrudates for all protein-loads (20–60%), the dispersive power of TSE revealed not to be decisive. Consequently, the ram extruder would be favored for the production of stable protein-loaded extrudates in small scale.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100196"},"PeriodicalIF":4.7,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9820477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma 可注射水凝胶缓释肝细胞癌治疗基因
IF 4.7 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2023-06-26 DOI: 10.1016/j.ijpx.2023.100195
Shuangta Xu , Jianya Cai , Hongwei Cheng , Wei Wang
{"title":"Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma","authors":"Shuangta Xu ,&nbsp;Jianya Cai ,&nbsp;Hongwei Cheng ,&nbsp;Wei Wang","doi":"10.1016/j.ijpx.2023.100195","DOIUrl":"10.1016/j.ijpx.2023.100195","url":null,"abstract":"<div><p>Gene therapy has shown remarkable effectiveness in the management of disease like cancer and inflammation as a revolutionary therapeutic. Nonetheless, therapeutic drug target discovery, efficient gene delivery, and gene delivery vehicles continue to be significant obstacles. Due to their effective gene transport capabilities and low immunogenicity, supramolecular polymers have garnered significant interest. Herein, ABHD5 is identified as a potential therapeutic target since it is dysregulated in hepatocellular carcinoma (HCC). Interestingly, the downregulation of ABHD5 could induce programmed death-ligand 1 (PD-L1) expression in liver cancer, which may contribute to the immunosuppression. To overcome the immunosuppression caused by PD-L1, an injectable hydrogel is designed to achieve efficient abhydrolase domain containing 5 (ABHD5) gene delivery via the host-guest interaction with branched polyethyleneimine-g-poly (ethylene glycol), poly (ethylene oxide) and poly (propylene oxide) block copolymers and α-CD (PPA/CD), demonstrating the capability for sustained gene release. The co-assembly hydrogel demonstrates good biocompatibility and enhanced gene transfection efficiency, efficiently triggering tumor cell apoptosis. Overall, the results of this study suggest that ABHD5 is a potential therapeutic target, and that a host-guest-based supramolecular hydrogel could serve as a promising platform for the inhibition of HCC.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"6 ","pages":"Article 100195"},"PeriodicalIF":4.7,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/99/main.PMC10336675.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9820479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信